Today’s AI Top Pick: GEHC

10/1/2026 · Bullish Consensus Reliable Bullish screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

The desk streams live daily· see the schedule →

Today's pick · Bullish Consensus Reliable BullishGEHCBUY NOW11.1 / 1010/1/2026

GE HealthCare is the only candidate that delivers a textbook multi-timeframe bullish convergence while also passing the fundamental screen on merit. On the 4h, 1d, and 1wk timeframes the forecast trend is uniformly positive: fc_mid_pct of 30.20, 7.16, and 9.53 respectively, with fc_long_pct of 29.99, 5.66, and 9.99 — every horizon pointing higher. Critically, it is NOT chasing: position_in_21bar_range_pct sits at 49.26 on the 4h (dead center of the range), 35.50 on the 1d, and 38.06 on the 1wk, with shallow drawdowns of just -2.05, -6.46, and -11.79 percent. This is a clean accumulation zone, not a blown-out top. The bullish probability is a full 1.0, and near_term_bullish is also 1.0, meaning both the model and the tape agree on upside. The fundamentals reinforce the technical setup rather than contradicting it. GEHC trades at a reasonable forward P/E of 12.02 on a trailing P/E of 15.02, with a healthy PEG of 1.26 and ROE of 19.19. Profitability is solid at a 9.33 percent profit margin and 39.37 percent gross margin, while sales growth of 6.52 percent YoY confirms the business is still expanding. Analyst support is strong: a recom of 1.57 (leaning buy) and a 26.6 percent target upside. Debt-to-equity at 0.96 is manageable for a capital-intensive medical device maker, and short float is a low-risk 3.76 percent. News is a clear tailwind, not a landmine. On 2026-09-30 GE HealthCare was upgraded to Buy by its analyst, raised its dividend by nearly 15 percent (a strong signal of management confidence in cash flows), and announced next-generation deep-learning MRI expansion with AsiaMedic. These are three simultaneous positive catalysts on the same day. Unlike ALNY (JPMorgan lowered expectations) or WAY (considering a take-private that creates uncertainty), GEHC has no negative headline undercutting the thesis. The entry is right now: waiting for a pullback risks missing the move since the stock is already mid-range with bullish forecast momentum across all horizons, and the dividend raise plus upgrade provide a fundamental floor. This is the rare confluence of strong fundamentals, clean multi-timeframe agreement, favorable positioning, and positive catalysts all at once.

Entry zone

Buy at or near current levels around $65.34-$66.00; add on any dip toward $62.50 (4h 21-bar support) which aligns with the shallow -2.05% drawdown floor

Stop loss

Exit below $61.50 (roughly -6% from entry), which would break the 1d/1wk bullish structure and the -11.79% 1wk drawdown tolerance

First target

$70.00 (near-term re-rate toward the 1d forecast expansion, roughly +6-7%)

Longer target

$78.00 (swing target aligning with the 26.6% analyst target upside and 1wk fc_long expansion of +9.99%)

Risks

Healthcare sector and medical device demand remain sensitive to healthcare policy and reimbursement changes that could pressure margins
Debt-to-equity of 0.96, while manageable, leaves less balance-sheet cushion than peers like WAY (0.37) or BZ (0.01) in a rising-rate environment
The 4h forecast shows a -2.05% drawdown from the 21-bar high, indicating near-term volatility that could trigger a quick stop if momentum stalls
Sales growth of only 6.52% YoY is modest relative to high-growth names like APLD (167%) or BEAM (159%), limiting multiple expansion
Concentration risk: the thesis relies heavily on the single-day cluster of upgrade + dividend raise + product news, any of which could fade quickly

Honorable mentions

ALGTSecond choice: perfect multi-timeframe bullish alignment (4h fc_mid +11.43, 1d fc_long -5.10 but 1h fc_long +16.37, 1wk fc_long +0.81) with a stellar 64.8% target upside and positive news flow (Sun Country merger synergies, World Airline Award). However, the 1d timeframe shows negative long-term forecast (-5.10%) and a 53.87 trailing P/E with razor-thin 0.86% profit margin make it a higher-risk pick than GEHC.

BZThird choice: bullish_prob 1.0 with exceptional fundamentals (10.48 P/E, 53.22% profit margin, 85.92% gross margin, 0.01 debt-to-equity) and 48.4% target upside. But the 1d timeframe shows a -10.34% drawdown with negative short/mid forecast (-2.65%, -0.08%), and near_term_bullish is only 0.2, signaling the tape is not yet confirming the fundamental strength — a BUY_PULLBACK setup until the daily forecast turns positive.

WAYFourth choice: strong fundamentals (13.48 fwd P/E, 1.2 recom, 32.9% upside) but the 4h shows a massive +26.83% recent move with position_in_21bar_range at 95.37% — it is at the top of the range and chasing. The take-private consideration headline adds binary event risk. BUY_PULLBACK only, waiting for a re-entry below the 4h range top.

ALNYFifth choice: bullish_prob 1.0 with 51.6% target upside and 95.14% sales growth. But the 4h shows a -18.03% drawdown with position_in_21bar_range at just 0.85% (near the bottom, so not chasing) yet JPMorgan lowered expectations on 2026-09-30, a headline landmine. near_term_bullish of 0.6 is middling. WAIT for the negative analyst revision to clear.

DSGXSixth choice: strong fundamentals (30.09 fwd P/E, 1.29 recom, 25.2% upside) and a 52.7% short float decline is a positive. But bullish_prob is 0.0 and near_term_bullish is 0.0 — the model is explicitly not bullish despite good fundamentals. The 1d shows fc_long at only +1.63% and 1wk fc_long at +3.33%, weak forecast magnitude. WAIT for the model to flip bullish.

POWISeventh choice: bullish_prob 1.0 with 57.7% target upside and CAPZero-4 product launch as a catalyst. But only the 1d timeframe is available (fc_long -0.17%), and the 115.94 trailing P/E with 3.62% ROE and 5.58% profit margin are stretched. near_term_bullish of 0.8 is decent but the single-timeframe data limits conviction. BUY_PULLBACK until more timeframes confirm.

NICEEighth choice: Oppenheimer upgrade to Outperform with $150 target is a positive catalyst. But bullish_prob is only 0.2 and near_term_bullish is 0.6, and all forecast horizons are negative (fc_mid -6.97%, fc_long -4.26%). The ugly growth numbers flagged in the headline weigh on the thesis. WAIT for the forecast tape to turn positive.

WMGNinth choice: near_term_bullish of 1.0 and Guggenheim Buy with $36 target. But bullish_prob is only 0.6, and all timeframes show negative drawdowns (1h -4.05%, 4h -4.05%, 1d -8.15%, 1wk -20.81%) with weak forecast magnitudes. The 21.83 P/E and 9.1% profit margin are mediocre. BUY_PULLBACK until the multi-timeframe alignment tightens.

PTCTenth choice: strong fundamentals (13.56 P/E, 41.67% profit margin, 82.89% gross margin) but only two timeframes available (1h, 4h) with modest forecast magnitudes (fc_long 1h +3.02%, 4h +11.21%). bullish_prob 0.8 and near_term_bullish 0.4 are middling. The 2.23 PEG signals stretched growth-adjusted valuation. WAIT for more timeframe confirmation.

MORNEleventh choice: bullish_prob 0.8 with solid fundamentals (13.63 fwd P/E, 31.96% ROE). But near_term_bullish is only 0.4, and the 4h shows position_in_21bar_range at 99.52% — essentially at the top of the range, a chase. The 1d shows a -9.42% drawdown with negative forecast. BUY_PULLBACK, waiting for re-entry below the 4h range.

ISRGTwelfth choice: near_term_bullish of 1.0 with strong margins (28.45% profit, 66.66% gross). But bullish_prob is only 0.8, the 62.32 RSI is approaching overbought territory, and the 1d shows fc_long of only +12.84% with a -1.98% drawdown. The 46.6 P/E is rich. BUY_PULLBACK given the elevated RSI and rich valuation.

EQPTThirteenth choice: 88.3% target upside is the highest on the list, with a Cummins collaboration and multi-year fleet deal as catalysts. But bullish_prob is null and near_term_bullish is null — the model has no conviction. The 224.13 P/E and 0.45% profit margin are extreme, and short float of 13.04% adds dilution risk. WAIT for the model to assign a probability.

CEFourteenth choice: bullish_prob 1.0 with chemical price increases as a margin catalyst. But all timeframes show negative drawdowns (4h -8.87%, 1d -8.52%, 1wk -21.85%) and the 1wk fc_long of +112% is an extreme outlier rather than clean alignment. The -24.57% ROE and -12.04% profit margin are weak. WAIT for the fundamentals to stabilize.

IPGPFifteenth choice: bullish_prob 1.0 with 58.6% target upside. But the 4h shows a -26.37% drawdown with position_in_21bar_range at 10.48%, and the 121.21 P/E with 2.58% profit margin are severely stretched. near_term_bullish of 0.8 is decent but the valuation demands caution. BUY_PULLBACK until the P/E compresses.

TTANSixteenth choice: bullish_prob 1.0 with a Ramp partnership as a strong catalyst and 48.2% target upside. But both timeframes show negative drawdowns (4h -17.3%, 1d -28.37%) and the null P/E with -8.34% ROE and -12.12% profit margin signal an unprofitable growth story. near_term_bullish of 0.4 is weak. WAIT for profitability confirmation.

GLXYSeventeenth choice: 78.6% target upside is attractive with an AI infrastructure narrative. But bullish_prob is null and near_term_bullish is null — no model conviction. The null P/E, -5.83% ROE, and -7.79% profit margin are weak, and short float of 16.56% adds dilution risk. WAIT for the model to assign a probability.

APLDEighteenth choice: bullish_prob 1.0 with a massive 167.3% target upside and 167.37% sales growth. But all timeframes show severe drawdowns (4h -33.07%, 1d -13.77%, 1wk -47.91%) and the null P/E with -21.89% ROE and -43.39% profit margin signal an unprofitable, capital-intensive story. Short float of 21.44% is a major dilution overhang. WAIT for the capital stack to de-risk.

BLSHNineteenth choice: 41.42 fwd P/E and 79.64% gross margin are attractive. But bullish_prob is null and near_term_bullish is null, and Keefe Bruyette lowered its target to Market Perform at $40 — a headline landmine. The -55.73% ROE and -390.07% profit margin are catastrophic. WAIT for the model to assign a probability and the analyst downgrade to clear.

SHWTwentieth choice: bullish_prob 1.0 with a Statesville facility opening as a catalyst. But near_term_bullish is 0.0, and all timeframes show negative drawdowns (1h -3.21%, 4h -3.55%, 1d -3.81%, 1wk -12.98%) with weak forecast magnitudes. The 29.8 P/E and 11% profit margin are reasonable but the tape is not confirming. WAIT for the multi-timeframe alignment to tighten.

PCTYTwenty-first choice: bullish_prob 0.0 and near_term_bullish of 0.6, with all timeframes showing negative forecast (fc_mid -20.32%, fc_long -15.8%). The BILL/Blackbaud partnership is a catalyst but the 28.84 P/E and 15.23% profit margin are not compelling enough to override the bearish tape. WAIT for the forecast to turn positive.

EXPOTwenty-second choice: bullish_prob 0.6 with an Investor Day as a catalyst and 28.4% target upside. But all timeframes show negative drawdowns (1h -0.82%, 4h -4.27%, 1d -6.19%, 1wk -8.14%) with modest forecast magnitudes. The 29.37 P/E and 17.67% profit margin are reasonable. WAIT for stronger multi-timeframe confirmation.

DLBTwenty-third choice: bullish_prob 1.0 with a Meta AI glasses upgrade as a strong catalyst and 34.4% target upside. But all timeframes show negative drawdowns (4h -0.10%, 1d -8.81%, 1wk -9.91%) and the forecast magnitudes are modest (fc_long 1d +10.62%, 1wk +16.57%). The 24.92 P/E is reasonable. BUY_PULLBACK given the negative drawdowns across all horizons.

SNPSTwenty-fourth choice: bullish_prob 0.8 with a $1bn silicon IP deal with Amazon and an Investor Day as strong catalysts. But all timeframes show negative forecast (fc_mid 4h -3.44%, fc_long 4h -4.65%) and the 76.84 P/E is extremely rich. The 1d shows fc_long of only +2.14%. BUY_PULLBACK until the forecast tape turns positive and the P/E de-rates.

BEAMTwenty-fifth choice: bullish_prob 1.0 with 108.9% target upside and 158.88% sales growth. But all timeframes show severe drawdowns (4h -35.88%, 1d -17.87%, 1wk -30.02%) and the null P/E with -8.08% ROE and -54.75% profit margin signal an unprofitable biotech. The base-editing lawsuit adds legal risk. WAIT for profitability and a cleaner technical setup.

CITwenty-sixth choice: bullish_prob 1.0 with a 8.13 fwd P/E and 25.7% target upside. But near_term_bullish is 0.0, and all timeframes show negative drawdowns (1h -1.63%, 4h -1.14%, 1d -6.22%, 1wk -8.22%) with weak forecast magnitudes. The 11.24 P/E and 2.27% profit margin are thin for a health insurer. WAIT for the multi-timeframe alignment to tighten.

PCORTwenty-seventh choice: bullish_prob 1.0 with a Piper Sandler Overweight and $68 target. But near_term_bullish is only 0.2, and the 4h shows position_in_21bar_range at 100% — fully at the top of the range, a chase. The null P/E with -3.12% ROE and -2.73% profit margin are weak. BUY_PULLBACK, waiting for re-entry below the 4h range.

APHTwenty-eighth choice: strong fundamentals (25.77 fwd P/E, 1.46 recom, 19.5% upside) with AI growth catalysts. But bullish_prob is 0.0 and near_term_bullish is 0.0 — the model is explicitly not bullish. The 4h shows a catastrophic -50.82% drawdown with position_in_21bar_range at 1.01%, and the 1wk fc_long of -64.41% is a bearish outlier. The 42.21 P/E is rich. AVOID until the model flips bullish.

Full ranking (28)

#	Symbol	Verdict	Score	Read
1	GEHC	BUY NOW	11.1	Perfect multi-timeframe bullish convergence with clean mid-range entry, strong fundamentals, and a triple catalyst (upgrade, dividend raise, product expansion) — the ideal confluence.
2	ALGT	BUY PULLBACK	10.9	Excellent multi-timeframe alignment and 64.8% upside but a 53.87 P/E with 0.86% margin and a negative 1d long forecast warrant a pullback entry.
3	BZ	BUY PULLBACK	10.7	Outstanding fundamentals and 48.4% upside but the 1d tape shows a -10.34% drawdown with negative forecast and near_term_bullish of only 0.2.
4	WAY	BUY PULLBACK	10.5	Strong fundamentals and 32.9% upside but the 4h is at 95.37% of its range (chasing) with take-private uncertainty as a headwind.
5	ALNY	WAIT	10.3	51.6% upside and 95% sales growth but JPMorgan lowered expectations and the 4h is at the bottom of a -18% drawdown range.
6	DSGX	WAIT	9.8	Great fundamentals and falling short interest but the model assigns 0.0 bullish probability and the forecast magnitude is weak.
7	POWI	BUY PULLBACK	9.4	57.7% upside and a product catalyst but only one timeframe is available and the 115.94 P/E is stretched.
8	NICE	WAIT	9.0	Oppenheimer upgrade is positive but bullish_prob is only 0.2 and all forecast horizons are negative.
9	WMG	BUY PULLBACK	8.6	near_term_bullish of 1.0 and a Buy rating but all timeframes show negative drawdowns and weak forecast magnitude.
10	PTC	WAIT	8.2	Strong margins but only two timeframes available and a 2.23 PEG signals stretched valuation.
11	MORN	BUY PULLBACK	7.9	Solid fundamentals but the 4h is at 99.52% of its range (chasing) with near_term_bullish of only 0.4.
12	ISRG	BUY PULLBACK	7.5	near_term_bullish of 1.0 and strong margins but the 62.32 RSI is near overbought and the 46.6 P/E is rich.
13	EQPT	WAIT	7.1	88.3% upside and a Cummins deal but the model assigns null probability and the 224.13 P/E is extreme.
14	CE	WAIT	6.8	Price increases are a catalyst but all timeframes show negative drawdowns and the -24.57% ROE is weak.
15	IPGP	BUY PULLBACK	6.4	58.6% upside but the 121.21 P/E with 2.58% margin and a -26% 4h drawdown demand caution.
16	TTAN	WAIT	6.0	Ramp partnership is a catalyst but both timeframes show negative drawdowns and the stock is unprofitable.
17	GLXY	WAIT	5.7	78.6% upside and an AI narrative but the model assigns null probability and the fundamentals are weak.
18	APLD	WAIT	5.3	167% upside and sales growth but severe drawdowns across all timeframes and a 21.44% short float overhang.
19	BLSH	WAIT	4.9	Attractive gross margin but Keefe Bruyette lowered its target and the model assigns null probability.
20	SHW	WAIT	4.6	Bullish probability of 1.0 but near_term_bullish is 0.0 and all timeframes show negative drawdowns.
21	PCTY	WAIT	4.2	A partnership is a catalyst but bullish_prob is 0.0 and all forecast horizons are negative.
22	EXPO	WAIT	3.9	Investor Day is a catalyst but all timeframes show negative drawdowns with weak forecast magnitude.
23	DLB	BUY PULLBACK	3.5	Meta upgrade is a strong catalyst but all timeframes show negative drawdowns and modest forecast magnitude.
24	SNPS	BUY PULLBACK	3.1	Amazon deal and Investor Day are catalysts but the 76.84 P/E is extreme and the 4h forecast is negative.
25	BEAM	WAIT	2.8	108.9% upside but severe drawdowns, unprofitability, and a base-editing lawsuit create too much risk.
26	CI	WAIT	2.4	Bullish probability of 1.0 but near_term_bullish is 0.0 and all timeframes show negative drawdowns.
27	PCOR	BUY PULLBACK	2.0	Piper Sandler Overweight is positive but the 4h is at 100% of its range (chasing) and the stock is unprofitable.
28	APH	AVOID	1.6	Strong fundamentals but the model assigns 0.0 bullish probability and the 4h shows a -50% drawdown with a bearish 1wk long forecast.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord